Inhibition of preadipocyte differentiation and adipogenesis by zinc-α2-glycoprotein treatment in 3T3-L1 cells

Journal of Diabetes Investigation

Volumn 4, Issue 3, 2013, Pages 252-260

  Zhu, Hui Juan ^a   Ding, Hui Hua ^a,b   Deng, Jie Ying ^a   Pan, Hui ^a   Wang, Lin Jie ^a   Li, Nai Shi ^a   Wang, Xiang Qing ^a   Shi, Yi Fan ^a   Gong, Feng Ying ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

3T3 L1 preadipocytes; Differentiation; Zinc 2 glycoprotein

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA2 GLYCOPROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID SYNTHASE; LIPID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOCYTE; ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOCHEMISTRY; DOWN REGULATION; GENE ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; INHIBITION KINETICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROADIPOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPECTROPHOTOMETRY; TIME;

EID: 84877074153     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12046     Document Type: Article

References (35)

1. Armani A, Mammi C, Marzolla V, et al. Cellular models for understanding adipogenesis adipose dysfunction obesity. J Cell Biochem 2010; 110: 564-572.
2. Bing C, Mracek T, Gao D, et al. Zinc-alpha2-glycoprotein: an adipokine modulator of body fat mass? Int J Obes (Lond) 2010; 34: 1559-1565.
3. Gao D, Trayhurn P, Bing C. Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes. Mol Cell Endocrinol 2010; 325: 135-142.
4. Bao Y, Bing C, Hunter L, et al. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41-47.
5. Gong FY, Zhang SJ, Deng JY, et al. Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond) 2009; 33: 1023-1030.
6. Zhang SJ, Gong FY, Deng JY, et al. [Construction of Zinc-alpha2-glycoprotein expression plasmid and its expression in 3t3-l1 preadipocytes]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2010; 32: 283-288 (Chinese).
7. Hirai K, Hussey HJ, Barber MD, et al. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 1998; 58: 2359-2365.
8. Selva DM, Lecube A, Hernandez C, et al. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 2009; 94: 4499-4507.
9. Mracek T, Gao D, Tzanavari T, et al. Downregulation of zinc-{alpha}2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-alpha in adipocytes. J Endocrinol 2010; 204: 165-172.
10. Byerley LO, Lee SH, Redmann S, et al. Evidence for a novel serum factor distinct from zinc alpha-2 glycoprotein that promotes body fat loss early in the development of cachexia. Nutr Cancer 2010; 62: 484-494.
11. Olofsson LE, Olsson B, Lystig T, et al. Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids. Metabolism 2010; 59: 1316-1318.
12. Russell ST, Tisdale MJ. Studies on the antiobesity effect of zinc-alpha(2)-glycoprotein in the ob/ob mouse. Int J Obes (Lond) 2011; 35: 345-354.
13. Russell ST, Tisdale MJ. Studies on the anti-obesity activity of zinc-alpha(2)-glycoprotein in the rat. Int J Obes (Lond) 2011; 35: 658-665.
14. Zhu HJ, Dong CX, Pan H, et al. rs4215 SNP in zinc-alpha2-glycoprotein gene is associated with obesity in Chinese north Han population. Gene 2012; 500: 211-215.
15. Gong FY, Deng JY, Zhu HJ, et al. Fatty acid synthase and hormone-sensitive lipase expression in liver are involved in zinc-alpha2-glycoprotein-induced body fat loss in obese mice. Chin Med Sci J 2010; 25: 169-175.
16. Gong FY, Shi YF, Deng JY. The regulatory mechanism by which interleukin-6 stimulates GH-gene expression in rat GH3 cells. J Endocrinol 2006; 190: 397-406.
17. Zhu HJ, Deng JY, Gong FY, et al. Primary culture of human preadipocyte in a serum-free medium. Basic Clin Med 2006; 7: 770-773.
18. Zhang C, Teng L, Shi Y, et al. Effect of emodin on proliferation and differentiation of 3T3-L1 preadipocyte and FAS activity. Chin Med J (Engl) 2002; 115: 1035-1038.
19. Qiu J, Gao CL, Zhang M, et al. LYRM1, a novel gene promotes proliferation and inhibits apoptosis of preadipocytes. Eur J Endocrinol 2009; 160: 177-184.
20. Kong CS, Kim JA, Eom TK, et al. Phosphorylated glucosamine inhibits adipogenesis in 3T3-L1 adipocytes. J Nutr Biochem 2010; 21: 438-443.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
22. Todorov PT, McDevitt TM, Meyer DJ, et al. Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res 1998; 58: 2353-2358.
23. Lei G, Brysk H, Arany I, et al. Characterization of zinc-alpha(2)-glycoprotein as a cell adhesion molecule that inhibits the proliferation of an oral tumor cell line. J Cell Biochem 1999; 75: 160-169.
24. He N, Brysk H, Tyring SK, et al. Zinc-alpha(2)-glycoprotein hinders cell proliferation and reduces cdc2 expression. J Cell Biochem Suppl 2001; 36(Suppl): 162-169.
25. Latasa MJ, Moon YS, Kim KH, et al. Nutritional regulation of the fatty acid synthase promoter in vivo: sterol regulatory element binding protein functions through an upstream region containing a sterol regulatory element. Proc Natl Acad Sci USA 2000; 97: 10619-10624.
26. Farmer SR. Regulation of PPARgamma activity during adipogenesis. Int J Obes (Lond) 2005; 29(Suppl 1): S13-S16.
27. Tontonoz P, Hu E, Graves RA, et al. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 1994; 8: 1224-1234.
28. Rosen ED, Spiegelman BM. Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache. J Clin Invest 2000; 106: 629-631.
29. Akune T, Ohba S, Kamekura S, et al. PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113: 846-855.
30. Choi JW, Liu H, Mukherjee R, et al. Downregulation of Fetuin-B and Zinc-alpha2-glycoprotein is linked to impaired fatty acid metabolism in liver cells. Cell Physiol Biochem 2012; 30: 295-306.
31. Russell ST, Zimmerman TP, Domin BA, et al. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-alpha2-glycoprotein. Biochim Biophys Acta 2004; 1636: 59-68.
32. Russell ST, Tisdale MJ. The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 2005; 92: 876-881.
33. Russell ST, Hirai K, Tisdale MJ. Role of beta3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer 2002; 86: 424-428.
34. Russell ST, Tisdale MJ. Role of beta-adrenergic receptors in the anti-obesity and anti-diabetic effects of zinc-alpha2-glycoprotien (ZAG). Biochim Biophys Acta 2012; 1821: 590-599.
35. Russell ST, Tisdale MJ. Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice. Endocrinology 2010; 151: 948-957.